ARTICLE | Company News
Hybrigenics SA, NiKem Research Srl deal
May 16, 2005 7:00 AM UTC
The companies extended their cancer research deal under which NiKem is using its medicinal chemistry technology to optimize Hybrigenics' inhibitors of ubiquitin-specific proteases. ...